Examkin

Question

Difficulty: Very hardPharmacologic Interventions

A 38-year-old man is admitted to the hospital for intravenous antibiotic therapy for right lower extremity cellulitis. His past medical history is significant for treatment-resistant schizophrenia, which has been well-controlled for three years on a stable dose of clozapine (500 mg daily). He smokes two packs of cigarettes per day. Because the hospital is a smoke-free facility, he is prescribed a 21-mg nicotine transdermal patch upon admission to prevent withdrawal symptoms. His admission laboratory studies, including a serum creatinine of 0.8 mg/dL and normal liver enzymes, are unremarkable. He is started on intravenous daptomycin. On hospital day 4, the patient experiences a first-time generalized tonic-clonic seizure. Vital signs immediately following the event are temperature 37.0°C (98.6°F), blood pressure 132/82 mmHg, heart rate 94/min, and respiratory rate 16/min. Neurologic examination demonstrates post-ictal confusion but no focal deficits.

Which of the following medication management strategies upon admission would have most likely prevented this patient's new-onset neurologic complication?

  1. A
    Replace the nicotine transdermal patch with a nicotine inhaler
  2. B
    Substitute daptomycin with an alternative antimicrobial agent
  3. Decrease the daily dosage of clozapine by 30% to 50%Answer
  4. D
    Co-administer carbamazepine to accelerate clozapine metabolism
  5. E
    Prescribe bupropion for smoking cessation instead of nicotine replacement

Answer

Decrease the daily dosage of clozapine by 30% to 50%
The correct intervention is to decrease the daily dosage of clozapine by 30% to 50%. Clozapine is heavily metabolized by the hepatic cytochrome P450 1A2 (CYP1A2) enzyme. Tobacco smoke contains polycyclic aromatic hydrocarbons (PAHs), which are potent inducers of CYP1A2. In heavy smokers, this induction increases clozapine clearance, requiring higher maintenance doses to achieve therapeutic efficacy. When a patient is admitted to a smoke-free environment, the sudden cessation of PAH exposure leads to a rapid decline in CYP1A2 activity over a few days. Consequently, clozapine metabolism slows, and serum levels can double or triple, leading to dose-dependent adverse effects such as generalized tonic-clonic seizures. Preemptively reducing the clozapine dose upon admission is necessary to prevent this life-threatening toxicity.

Step-by-Step Solution

1
Identify the cause of the patient's new-onset seizure.
The seizure is due to clozapine toxicity.
Clozapine lowers the seizure threshold in a dose-dependent manner. The patient's hospitalization in a smoke-free facility caused a sudden pharmacokinetic shift.
2
Analyze the mechanism of the pharmacokinetic shift.
Loss of polycyclic aromatic hydrocarbons (PAHs) led to decreased CYP1A2 activity.
Tobacco smoke contains PAHs, which strongly induce CYP1A2. Sudden cessation of PAH exposure leads to a rapid rise in serum levels of clozapine, a major CYP1A2 substrate.
3
Determine the appropriate preventive intervention.
The clozapine dose must be empirically reduced upon admission to a smoke-free facility.
A preemptive dose reduction of 30% to 50% accounts for the loss of enzyme induction and prevents dose-dependent toxicity.
4
Evaluate alternative options for contraindications.
Carbamazepine and bupropion are contraindicated.
Carbamazepine increases agranulocytosis risk; bupropion further lowers the seizure threshold.

Key Concept

Patients stabilized on clozapine require a preemptive dose reduction of 30% to 50% when admitted to a smoke-free environment to prevent toxicity (e.g., seizures) caused by the sudden loss of CYP1A2 induction from tobacco smoke.
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic